Senior insider sale
EVP, GMDA at VERTEX PHARMACEUTICALS INC / MA — senior position signals high conviction
$6.82M
14.97K shares
What this filing means
BOZIC CARMEN plans to sell 14.97K shares of VERTEX PHARMACEUTICALS INC / MA valued at approximately $6.82M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/29/2026ACC: 0001959173-26-004132
Officer· EVP, GMDA
Since Oct 2019
14.97K
Shares to sell
$6.82M
Approx. market value
1.97K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months2
Restricted Stock Vesting
Compensation
2/24/2026
954.00Restricted Stock Vesting
Compensation
2/17/2026
1.02KTotal acquired1.97K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/24/2026 | Restricted Stock Vesting Compensation | 954.00 | — |
2/17/2026 | Restricted Stock Vesting Compensation | 1.02K | — |
| Total | 1.97K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
1.35K
Market value
$614.0K
5/15/2026
—Completed
Units to sell
6.99K
Market value
$3.14M
5/12/2026
—Completed
Units to sell
2.33K
Market value
$1.05M
3/27/2026
—Completed
Units to sell
2.33K
Market value
$1.12M
3/13/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.97K
Market value
$888.3K
5/29/2026
Total
Units
14.97K
Value
$6.82M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/15/2026 | 1.35K | $614.0K | — | Completed |
5/12/2026 | 6.99K | $3.14M | — | Completed |
3/27/2026 | 2.33K | $1.05M | — | Completed |
3/13/2026 | 2.33K | $1.12M | — | Completed |
| Planned — Approximate Date | ||||
5/29/2026 | 1.97K | $888.3K | NASDAQ | Planned |
| Total | 14.97K | $6.82M | ||